Hepes-M199 Buffered
Cryoprotectant:EG+DMSO(1:1)+ Sucrose
Ready-to-use with HSA
The ideal choice for efficient and dependable cryopreservation in your lab. Engineered to simplify your workflow.
VitaVitro successfully launched our products in the U.S. in 2019, in Europe and other countries shortly thereafter, and in China in 2021. Our unwavering commitment to excellent quality and reliable outcomes has earned us high customer satisfaction across all markets.
Classic HEPES-M199 buffer system.
The combination of DMSO and Ethylene Glycol in the media ensures reduced toxicity and optimal outcomes after warming.
VitaVitro's media offers a 12-month shelf life without gentamicin, ensuring a safer and antibiotic-free environment.
Custom procedures designed specifically for oocytes to ensure better outcomes.
Sucrose 1M
HEPES-M199 Buffered
Ready-to-use with HSA
The 1M sucrose formulation with HSA and ultra-fast warming protocol minimize embryo exposure to non-physiological conditions, fundamentally reducing the risks of osmotic shock and ice crystal reformation. This provides a safer recovery environment for embryos while significantly reducing operational complexity and improving efficiency.
VitaVitro ultra-fast warming protocol are not only optimized for our own cryopreservation products but are also designed with broad applicability in mind. They enable efficient warming of embryos/oocytes cryopreserved with different brands of vitrification kits, providing laboratories with an integrated and reliable solution.1
Clinical evidence published in 2025 from European studies, together with the first clinical RCT in China, demonstrated that the ultra-fast warming protocol reduces the operation time to 1 minute (approximately 90% shorter) while maintaining favorable implantation outcomes in clinical practice.
1.Parmegiani L, Vajta G, Lynch C, Arnone A, Bernardi S, Maccarini AM,et al. Universal post-warming dilution of vitrified embryos: impact of different vitrification/warming kits, warming volume and rapid dilution/rehydration steps on survival and clinical outcomes. Reprod Biomed Online. 2025 Sep;51(3). doi:10.1016/j.rbmo.2025.104923.
VitaVitro UFW white paper
download
The primordial follicle preservation rate reached 57% (compared to only 33% with conventional slow thawing, p=0.0266).
Significantly lower apoptosis levels compared to the conventional thawing group (TUNEL assay, p=0.014). Lowest VEGF-A stress secretion (combined with apoptosis data, indicating minimal tissue damage)
Operation time reduced from 77 minutes to 16 minutes, achieving a 79.2% increase in operational efficiency.
1.Färber CM, Einenkel R, Emrich NLA, Kestermann EZ, Parmegiani L, Schallmoser A, et al. Towards a universal rapid warming protocol for cryopreserved human ovarian tissue. Reprod Biomed Online. 2025 Jul 14 [Online ahead of print]. doi:10.1016/j.rbmo.2025.105151.
step-by-step on-time instructions during the whole vitrification-warming process with a built-in stopwatch function
interactive personalized information with options to choose the appropriate route
ample possibility to obtain background information opinions and suggestions
direct contact to the inventor and producer
Android OS
iOSpH 7.2-7.6
Endotoxin < 0.25 EU/mL
Mouse embryo assay ≥ 80%
Sterility test
| PRODUCT NAME | Catalog No. | SPECIFICATIONS | Shelf Life |
|---|---|---|---|
| VitaVitro Vitrification Kit | V002001 | HHM 1.0mL x1 HV1 1.0mL x1 HV2 1.0mL x1< | 12 months |
| V002002 | HHM 4.5mL x1 HV1 4.5mL x1 HV2 4.5mL x2 | ||
| V002004 | HHM 2.0mL x1 HV1 2.0mL x2 HV2 2.0mL x2 | ||
| V002007 | HHM 30mL x1 HV1 30mL x1 HV2 30mL x1 | ||
| VitaVitro Warming Kit | V003001 | HHM 1.8mL x1 HW1 1.5mL x2 HW2 1.0mL x1 | 12 months |
| V003002 | HHM 4.5mL x2 HW1 4.5mL x1 HW2 4.5mL x1 | ||
| V003004 | HHM 2.0mL x3 HW1 2.0mL x5 HW2 2.0mL x2 | ||
| V003007 | HHM 30mL x2 HW1 30mL x2 HW2 30mL x1 | ||
| VitaVitro Ultra-Fast Warming Kit |
─ | 1.0 mL*5 4.0 mL*5 |
12 months |
User guide
download
